1
|
Acceptable blood pressure control (<140/90 mm Hg, except in diabetes patients: <130/80 mm Hg.
|
2
|
Acceptable diabetes control, with a target of glycated haemoglobin (HbA1c) <7%
|
3
|
Blood pressure screening
|
4
|
Diabetes mellitus screening
|
5
|
Cardiovascular risk calculation in patients aged 35–74 years with total cholesterol >200 mg/dl
|
6
|
Alcohol consumption screening (adult population)
|
7
|
Ex-smokers, at one year
|
8
|
Ischemic heart disease patients with adequate antiplatelet treatment
|
9
|
Ischemic heart disease patients with low density lipoprotein <100 mg/ml
|
10
|
Cardiac arrhythmia patients with atrial fibrillation and anticoagulation treatment
|
11
|
Population >74 years attended and assigned, including home health care
|
12
|
Population >74 years attended and assigned, including home health care, with evaluation
|
13
|
Flu vaccine administered in the assigned population aged 60 years or more
|
14
|
Patients with chronic obstructive pulmonary disease and pneumococcal vaccine administered
|
15
|
Use of generic pharmaceutical specialties
|
16
|
Use of new medications with limited added value
|
17
|
Average cost per defined daily doses of proton pump inhibitors
|
18
|
Average cost per defined daily dose of statins
|
19
|
Average cost per defined daily dose of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptors antagonists (Angio II)
|
20 |
Average cost per defined daily dose of serotonin re-uptake inhibitors and new-generation antidepressants |